Orthostatic Hypotension Drugs Market, Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: O015AEA1706DEN
Market Monitor Global

Abstracts

The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.

This report contains market size and forecasts of Orthostatic Hypotension Drugs in Global, including the following market information:

Global Orthostatic Hypotension Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Orthostatic Hypotension Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Midodrine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Orthostatic Hypotension Drugs include Amneal Pharmaceuticals Inc., H. Lundbeck AS, Mylan NV, Novartis AG and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Orthostatic Hypotension Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Orthostatic Hypotension Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Orthostatic Hypotension Drugs Market Segment Percentages, by Type, 2021 (%)

• Midodrine
• Northera (droxidopa)
• Fludrocortisone
• Other Drugs

Global Orthostatic Hypotension Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Orthostatic Hypotension Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Institute
• Clinic
• Other

Global Orthostatic Hypotension Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Orthostatic Hypotension Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Orthostatic Hypotension Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Orthostatic Hypotension Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amneal Pharmaceuticals Inc.
• H. Lundbeck AS
• Mylan NV
• Novartis AG
• Pfizer Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Orthostatic Hypotension Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Orthostatic Hypotension Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORTHOSTATIC HYPOTENSION DRUGS OVERALL MARKET SIZE

2.1 Global Orthostatic Hypotension Drugs Market Size: 2021 VS 2028
2.2 Global Orthostatic Hypotension Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Orthostatic Hypotension Drugs Players in Global Market
3.2 Top Global Orthostatic Hypotension Drugs Companies Ranked by Revenue
3.3 Global Orthostatic Hypotension Drugs Revenue by Companies
3.4 Top 3 and Top 5 Orthostatic Hypotension Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Orthostatic Hypotension Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthostatic Hypotension Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Orthostatic Hypotension Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Orthostatic Hypotension Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Orthostatic Hypotension Drugs Market Size Markets, 2021 & 2028
  4.1.2 Midodrine
  4.1.3 Northera (droxidopa)
  4.1.4 Fludrocortisone
  4.1.5 Other Drugs
4.2 By Type - Global Orthostatic Hypotension Drugs Revenue & Forecasts
  4.2.1 By Type - Global Orthostatic Hypotension Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Orthostatic Hypotension Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Orthostatic Hypotension Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Orthostatic Hypotension Drugs Revenue & Forecasts
  5.2.1 By Application - Global Orthostatic Hypotension Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Orthostatic Hypotension Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Orthostatic Hypotension Drugs Market Size, 2021 & 2028
6.2 By Region - Global Orthostatic Hypotension Drugs Revenue & Forecasts
  6.2.1 By Region - Global Orthostatic Hypotension Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Orthostatic Hypotension Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Orthostatic Hypotension Drugs Revenue, 2017-2028
  6.3.2 US Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.3.3 Canada Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.3.4 Mexico Orthostatic Hypotension Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Orthostatic Hypotension Drugs Revenue, 2017-2028
  6.4.2 Germany Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.3 France Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.4 U.K. Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.5 Italy Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.6 Russia Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.4.8 Benelux Orthostatic Hypotension Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Orthostatic Hypotension Drugs Revenue, 2017-2028
  6.5.2 China Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.5.3 Japan Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.5.4 South Korea Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.5.6 India Orthostatic Hypotension Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Orthostatic Hypotension Drugs Revenue, 2017-2028
  6.6.2 Brazil Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.6.3 Argentina Orthostatic Hypotension Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, 2017-2028
  6.7.2 Turkey Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.7.3 Israel Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Orthostatic Hypotension Drugs Market Size, 2017-2028
  6.7.5 UAE Orthostatic Hypotension Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amneal Pharmaceuticals Inc.
  7.1.1 Amneal Pharmaceuticals Inc. Corporate Summary
  7.1.2 Amneal Pharmaceuticals Inc. Business Overview
  7.1.3 Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Major Product Offerings
  7.1.4 Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue in Global Market (2017-2022)
  7.1.5 Amneal Pharmaceuticals Inc. Key News
7.2 H. Lundbeck AS
  7.2.1 H. Lundbeck AS Corporate Summary
  7.2.2 H. Lundbeck AS Business Overview
  7.2.3 H. Lundbeck AS Orthostatic Hypotension Drugs Major Product Offerings
  7.2.4 H. Lundbeck AS Orthostatic Hypotension Drugs Revenue in Global Market (2017-2022)
  7.2.5 H. Lundbeck AS Key News
7.3 Mylan NV
  7.3.1 Mylan NV Corporate Summary
  7.3.2 Mylan NV Business Overview
  7.3.3 Mylan NV Orthostatic Hypotension Drugs Major Product Offerings
  7.3.4 Mylan NV Orthostatic Hypotension Drugs Revenue in Global Market (2017-2022)
  7.3.5 Mylan NV Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Orthostatic Hypotension Drugs Major Product Offerings
  7.4.4 Novartis AG Orthostatic Hypotension Drugs Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Pfizer Inc.
  7.5.1 Pfizer Inc. Corporate Summary
  7.5.2 Pfizer Inc. Business Overview
  7.5.3 Pfizer Inc. Orthostatic Hypotension Drugs Major Product Offerings
  7.5.4 Pfizer Inc. Orthostatic Hypotension Drugs Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Orthostatic Hypotension Drugs Market Opportunities & Trends in Global Market
Table 2. Orthostatic Hypotension Drugs Market Drivers in Global Market
Table 3. Orthostatic Hypotension Drugs Market Restraints in Global Market
Table 4. Key Players of Orthostatic Hypotension Drugs in Global Market
Table 5. Top Orthostatic Hypotension Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Orthostatic Hypotension Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Orthostatic Hypotension Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Orthostatic Hypotension Drugs Product Type
Table 9. List of Global Tier 1 Orthostatic Hypotension Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orthostatic Hypotension Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Orthostatic Hypotension Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Orthostatic Hypotension Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Amneal Pharmaceuticals Inc. Corporate Summary
Table 31. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Product Offerings
Table 32. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue (US$, Mn), (2017-2022)
Table 33. H. Lundbeck AS Corporate Summary
Table 34. H. Lundbeck AS Orthostatic Hypotension Drugs Product Offerings
Table 35. H. Lundbeck AS Orthostatic Hypotension Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Mylan NV Corporate Summary
Table 37. Mylan NV Orthostatic Hypotension Drugs Product Offerings
Table 38. Mylan NV Orthostatic Hypotension Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Orthostatic Hypotension Drugs Product Offerings
Table 41. Novartis AG Orthostatic Hypotension Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Inc. Corporate Summary
Table 43. Pfizer Inc. Orthostatic Hypotension Drugs Product Offerings
Table 44. Pfizer Inc. Orthostatic Hypotension Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Orthostatic Hypotension Drugs Segment by Type in 2021
Figure 2. Orthostatic Hypotension Drugs Segment by Application in 2021
Figure 3. Global Orthostatic Hypotension Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Orthostatic Hypotension Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Orthostatic Hypotension Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orthostatic Hypotension Drugs Revenue in 2021
Figure 8. By Type - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 12. US Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 24. China Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. H. Lundbeck AS Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan NV Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Inc. Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)